Osteopontin expression in primary sarcomas of the pulmonary artery.
Primary tumors of the great vessels (aorta, pulmonal artery, and inferior vena cava) are rare and represent in most cases vascular leiomyosarcomas. Furthermore, there also exists a group of sarcomas arising from the intima, known as intimal sarcomas, associated with early metastasis and a very poor prognosis. Osteopontin (OPN) is an extracellular matrix protein that binds to alphav integrins, thereby promoting cell attachment, chemotaxis, and signal transduction. The reported association of OPN with malignancy and metastasis prompted us to examine the expression of this protein in seven sarcomas of the pulmonary artery. Strong OPN-specific staining could be detected in tumor cells and the adjacent extracellular matrix. Using a double labeling procedure, proliferating cells showed a strong positive reaction with antibodies against OPN. In addition, this protein could be demonstrated in the cytoplasm of macrophages. CD44, a putative receptor of OPN, was expressed on the cellular surface of tumor-associated lymphocytes. The expression of OPN in macrophages and tumor cells indicates that this molecule could possibly mediate cellular adhesion of both cell types in pulmonary sarcomas. The detection in the extracellular matrix shows that OPN is actively secreted and may interact with the corresponding receptor, CD44, on the surface of lymphocytes. Although the function of OPN is not yet fully understood, our data indicate that strong expression of this molecule in poorly differentiated sarcomas could play a role in the progression of malignancy and metastasis as described previously for carcinomas.
Gaumann
A
A
MPI für Physiologische und Klinische Forschung, W.G. Kerckhoff Institut, Abt für Molekulare Zellbiologie, Bad Nauheim, Germany. andreas-gaumann@gmx.de
Petrow
P
P
Mentzel
T
T
Mayer
E
E
Dahm
M
M
Otto
M
M
Kirkpatrick
C J
CJ
Kriegsmann
J
J
D000328:Adult; D005109:Extracellular Matrix / Q000737:chemistry / Q000378:metabolism; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D018960:Hyaluronan Receptors / Q000032:analysis / Q000378:metabolism; D007124:Immunoenzyme Techniques; D007890:Leiomyosarcoma / Q000737:chemistry / Q000378:metabolism* / Q000556:secondary; D008264:Macrophages / Q000737:chemistry / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D053495:Osteopontin; D011651:Pulmonary Artery / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology; D012795:Sialoglycoproteins / Q000032:analysis / Q000096:biosynthesis*; D019043:Vascular Neoplasms / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology
D018960:Hyaluronan Receptors; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D053495:Osteopontin